Hearing on "Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development"
The Subcommittee on Health of the Committee on Energy and Commerce held a hearing on Wednesday, July 15, 2026, at 10:15 a.m. (ET) in the John D. Dingell Room, 2123 Rayburn House Office Building. The hearing is entitled "Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development."
Key Documents
Opening Statement of Full Committee Ranking Member Pallone as prepared for delivery
Opening Statement of Subcommittee Ranking Member DeGette as prepared for delivery
Livestream
Witnesses
Cynthia Verst, PharmD, MS
President, Design and Delivery Innovation, R&D Solutions
IQVIA
Susan C. Winckler, RPh, Esq.
CEO
Reagan-Udall Foundation for the FDA
Aaron J. Kowalski, PhD
CEO
Breakthrough T1D
Thomas Hwang, MD
Assistant Professor of Medicine
Brigham and Women's Hospital and Harvard Medical School
Thomas K. Bollyky, JD
Bloomberg Chair in Global Health,
Senior Fellow for International Economics, Law, and Development
Director of the Global Health Program, Council on Foreign Relations